ascopubs.org

Camrelizumab plus apatinib after progression on immune checkpoint inhibitors in patients with advanced esophageal squamous cell carcinoma (CAP 02 Re-challenge): A single-arm ...

A phase 2, open-label study of amivantamab in patients with previously treated advanced or metastatic gastric or esophageal cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Gastrointestinal ...
ascopubs.org

Real-world effectiveness and treatment (tx) patterns in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance ...

Evaluation of avelumab first-line (1L) maintenance therapy and subsequent treatment (tx) in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) using a large claims ...